378 related articles for article (PubMed ID: 16427342)
1. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages.
Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV
FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103
[TBL] [Abstract][Full Text] [Related]
3. Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis.
Albohy A; Li MD; Zheng RB; Zou C; Cairo CW
Glycobiology; 2010 Sep; 20(9):1127-38. PubMed ID: 20511247
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
[TBL] [Abstract][Full Text] [Related]
5. Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids.
Magesh S; Savita V; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
Bioorg Med Chem; 2009 Jul; 17(13):4595-603. PubMed ID: 19450982
[TBL] [Abstract][Full Text] [Related]
6. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and biochemical characterization of sialidases from zebrafish (Danio rerio).
Manzoni M; Colombi P; Papini N; Rubaga L; Tiso N; Preti A; Venerando B; Tettamanti G; Bresciani R; Argenton F; Borsani G; Monti E
Biochem J; 2007 Dec; 408(3):395-406. PubMed ID: 17708749
[TBL] [Abstract][Full Text] [Related]
8. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.
Zhang Y; Albohy A; Zou Y; Smutova V; Pshezhetsky AV; Cairo CW
J Med Chem; 2013 Apr; 56(7):2948-58. PubMed ID: 23530623
[TBL] [Abstract][Full Text] [Related]
9. New insights on the sialidase protein family revealed by a phylogenetic analysis in metazoa.
Giacopuzzi E; Bresciani R; Schauer R; Monti E; Borsani G
PLoS One; 2012; 7(8):e44193. PubMed ID: 22952925
[TBL] [Abstract][Full Text] [Related]
10. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells.
Seyrantepe V; Landry K; Trudel S; Hassan JA; Morales CR; Pshezhetsky AV
J Biol Chem; 2004 Aug; 279(35):37021-9. PubMed ID: 15213228
[TBL] [Abstract][Full Text] [Related]
11. Nile Tilapia Neu3 sialidases: molecular cloning, functional characterization and expression in Oreochromis niloticus.
Chigwechokha PK; Komatsu M; Itakura T; Shiozaki K
Gene; 2014 Nov; 552(1):155-64. PubMed ID: 25234733
[TBL] [Abstract][Full Text] [Related]
12. Novel Nile tilapia Neu1 sialidases: Molecular cloning and biochemical characterization of the sialidases Neu1a and Neu1b.
Honda A; Chigwechokha PK; Takase R; Hayasaka O; Fujimura K; Kotani T; Komatsu M; Shiozaki K
Gene; 2020 Jun; 742():144538. PubMed ID: 32184168
[TBL] [Abstract][Full Text] [Related]
13. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
Zhou Z; Bates M; Madura JD
Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of sialidases in human normal and tumor tissues.
Forcella M; Mozzi A; Stefanini FM; Riva A; Epistolio S; Molinari F; Merlo E; Monti E; Fusi P; Frattini M
Cancer Biomark; 2018 Feb; 21(3):591-601. PubMed ID: 29278877
[TBL] [Abstract][Full Text] [Related]
15. Mammalian sialidases: physiological and pathological roles in cellular functions.
Miyagi T; Yamaguchi K
Glycobiology; 2012 Jul; 22(7):880-96. PubMed ID: 22377912
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for substrate specificity of mammalian neuraminidases.
Smutova V; Albohy A; Pan X; Korchagina E; Miyagi T; Bovin N; Cairo CW; Pshezhetsky AV
PLoS One; 2014; 9(9):e106320. PubMed ID: 25222608
[TBL] [Abstract][Full Text] [Related]
17. Sialidase NEU3 and its pathological significance.
Miyagi T; Yamamoto K
Glycoconj J; 2022 Oct; 39(5):677-683. PubMed ID: 35675020
[TBL] [Abstract][Full Text] [Related]
18. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.
Li Y; Cao H; Yu H; Chen Y; Lau K; Qu J; Thon V; Sugiarto G; Chen X
Mol Biosyst; 2011 Apr; 7(4):1060-72. PubMed ID: 21206954
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
Albohy A; Mohan S; Zheng RB; Pinto BM; Cairo CW
Bioorg Med Chem; 2011 May; 19(9):2817-22. PubMed ID: 21489803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
